|
|
News Breaks
|
November 4, 2009
|
| 08:45 EDT |  | ONXX |
| theflyonthewall.com: | Onyx Pharma weakness creates attractive entry point, says Morgan Joseph | | After Onyx reported higher than expected Q3 EPS, Morgan Joseph believes what it sees as the company's strong fundamentals and the potential for attractive clinical data from Onyx's Carfilzomib, along with recent weakness in the stock, have created an attractive entry point. The firm maintains a Buy rating. :theflyonthewall.com |
|
|
News For ONXX From The Last 14 Days Check below for free stories on ONXX the last two weeks.
There are 3 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
|
|
|
Subscribe for More Information
